Asthma and rhinitis /

Saved in:
Bibliographic Details
Edition:2nd ed.
Imprint:Oxford ; Malden, MA, USA : Blackwell Science, 2000.
Description:2 v. : ill. ; 29 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4353983
Hidden Bibliographic Details
Other authors / contributors:Busse, W. W. (William W.)
Holgate, S. T.
ISBN:0632041757
Notes:Includes bibliographical references and index.
Table of Contents:
  • Contributors
  • Foreword
  • Preface to Second Edition
  • Preface to First Edition
  • Volume 1.
  • Part 1. Disease Classification
  • 1. Asthma: clinical descriptions and definitions
  • 2. Rhinitis: the spectrum of the disease
  • Part 2. Epidemiology
  • 3. Epidemiology of asthma
  • 4. Epidemiology of rhinitis
  • 5. Epidemiology of occupational asthma
  • 6. Epidemiology of asthma mortality
  • Part 3. Genetics
  • 7. Genetic approaches to studying asthma
  • 8. Antigen and transgenic modelling of asthma and airways hyperreactivity
  • 9. The use of small animal models in the study of asthma
  • 10. Genetics of atopy
  • 11. Genetics of asthma and bronchial hyperresponsiveness
  • 12. Genetic and molecular regulation of [beta subscript 2]-adrenergic receptors
  • Part 4. Anatomy, Development and Physiology
  • 13. Nasal airways
  • 14. Structural, immunological and neural elements of the normal human airway wall
  • Part 5. Pathology
  • 15. The pathology of fatal asthma
  • 16. The pathology of asthma of varying severity
  • 17. Bronchoalveolar lavage in studies of asthma
  • 18. Nasal polyposis: a model of chronic airways inflammation
  • 19. Allergic and non-allergic rhinitis
  • Part 6. Mast Cells and Basophils
  • 20. Development and maturation of mast cells and basophils
  • 21. Mast cells and basophils: IgE and its receptors
  • 22. Human mast cells and basophils: heterogeneity and mediators
  • 23. Mechanisms of mast cell activation
  • 24. Mast cells in rhinitis
  • 25. Mast cells in asthma
  • 26. Basophils in airways disease
  • Part 7. Eosinophils
  • 27. Human eosinophils--development, maturation and functional morphology
  • 28. Mechanisms of eosinophil activation
  • 29. Eosinophil mediators
  • 30. The eosinophil and asthma
  • 31. Eosinophils and rhinitis
  • Part 8. Neutrophils and Platelets
  • 32. Neutrophils and their mediators in asthma
  • 33. Neutrophils and asthma
  • 34. Platelets
  • Part 9. Lymphocytes
  • 35. Mucosa-associated lymphoid tissue of the lung: localization, numbers and dynamics of lymphoid cells in the five different compartments
  • 36. Lymphocyte substances in allergic diseases
  • 37. Cytokines in allergic airway disease
  • 38. Regulation of immunoglobulin Esynthesis
  • 39. The lymphocyte in asthma
  • 40. The lymphocyte in rhinitis
  • 41. Functional heterogeneity of T-lymphocytes in the development of airway hyperresponsiveness
  • Part 10. Macrophages, Monocytes and Dendritic Cells
  • 42. Alveolar macrophages in asthma
  • 43. Professional antigen-presenting cells
  • 44. Antigen presentation in the asthmatic lung
  • Part 11. Microvasculature
  • 45. The role and contribution of adhesion molecules to asthma and pulmonary disease
  • 46. Leukocyte-endothelial adhesion
  • 47. Microvascular anatomy of the airways
  • 48. In vivo processes of exudative airway inflammation with ultimate eosinophil activation and epithelial injury-repair
  • 49. Vascular mechanisms in asthma
  • Part 12. Epithelial Cells
  • 50. Structure, composition and function of airway surface liquid
  • 51. Mediator functions of epithelial cells
  • 52. Regulation of epithelial-leukocyte interaction and epithelial immune-response genes
  • 53. Epithelial cells: regulation of mucus secretion
  • 54. Epithelial damage in asthma
  • 55. Epithelial cell dysfunction in rhinitis
  • Part 13. Neuroregulation
  • 56. Neuroanatomy of the airways
  • 57. Functional activity of lower airway nerves
  • 58. Airway neuropeptides
  • 59. Neural reflex pathways in rhinitis
  • 60. Muscarinic receptors
  • 61. Neural regulation of the immune response
  • 62. Neuroregulation of mucosal vasculature
  • Part 14. Mediators of Inflammation
  • 63. Histamine and its receptors
  • 64. The roles of neutral proteases in asthma and rhinitis
  • 65. Prostanoids
  • 66. Leukotrienes
  • 67. Adenosine: its contribution to our understanding of asthma
  • 68. Chemokines and eosinophils
  • 69. Kinins
  • 70. Chemokines
  • Index
  • Volume 2.
  • Part 15. Role of Allergens in Airway Disease
  • 71. Aerobiology
  • 72. The molecular biology of allergens
  • 73. House-dust mite proteinase allergens and their interaction with the bronchial epithelium
  • 74. The role of house-dust mite and other allergens in asthma
  • 75. The early and late asthmatic response to allergen
  • 76. Primary allergic sensitization to inhalant allergens: adult responder phenotype is determined during early childhood
  • 77. The role of environmental allergens in rhinitis
  • Part 16. Pathophysiology
  • 78. Animal models of asthma
  • 79. Animal models of rhinitis
  • 80. Airway mechanics in asthma
  • 81. Airway hyperresponsiveness
  • 82. Nasal hyperresponsiveness
  • 83. Inflammatory mechanisms in airway hyperresponsiveness
  • 84. Mechanisms of cough
  • 85. Mechanisms of nocturnal asthma
  • 86. Aspirin-sensitive asthma
  • 87. Transcription factors in asthma
  • 88. Interrelationship between asthma and chronic obstructive pulmonary disease
  • 89. Intrinsic asthma
  • Part 17. Smooth Muscle Response
  • 90. The physiology of airway smooth muscle, and its dynamics in the bronchial wall during development and in maturity
  • 91. The role of inflammation in the regulation of airway smooth muscle cell function and growth
  • 92. Airway smooth muscle dysfunction in asthma
  • 93. Epithelial control over smooth-muscle responsiveness
  • Part 18. Exercise-Induced Asthma
  • 94. Exercise-induced asthma: clinical manifestations
  • 95. Dry-air and hyperosmolar challenge in asthma and rhinitis
  • 96. Vascular mechanisms in exercise-induced asthma
  • Part 19. Infectious Mechanisms in Asthma and Rhinitis
  • 97. Common colds and respiratory viruses
  • 98. Effects of viral infections on lower airway function
  • 99. Otitis media and sinusitis
  • Part 20. Mechanisms of Action of Drugs for the Treatment of Asthma and Rhinitis
  • 100. Mechanisms of action of [beta subscript 2]-adrenoceptor agonists
  • 101. Methylxanthines and phosphodiesterase inhibitors
  • 102. Glucocorticoids in asthma and rhinitis
  • 103. Glucocorticoid-insensitive bronchial asthma
  • 104. Non-steroidal antiinflammatory drugs in asthma
  • 105. Immunosuppressants
  • 106. Antileukotrienes
  • 107. Antihistamines in rhinitis and asthma
  • 108. Antiallergic and vasoactive drugs for rhinitis
  • 109. Activation of allergen-reactive T-lymphocytes and mechanisms of hyposensitization
  • 110. Specific immunotherapy in allergic rhinitis and asthma
  • 111. Antiallergic drugs
  • 112. Drug delivery devices and propellants
  • Part 21. Clinical Management of Asthma
  • 113. Diagnosis in adults
  • 114. Prevention of asthma
  • 115. Treatment of chronic asthma
  • 116. Education and training
  • 117. The health economics of asthma
  • 118. Outcome measures in asthma management
  • Part 22. Asthma in Special Circumstances
  • 119. Asthma and rhinitis during pregnancy
  • 120. Asthma and surgery
  • 121. Management of exercise-induced bronchoconstriction
  • 122. Critical care management
  • 123. Recalcitrant asthma
  • 124. Anaphylaxis
  • 125. Asthma in the elderly
  • Part 23. Management of Asthma in Childhood
  • 126. The wheezing infant and young child
  • 127. Development of asthma through childhood
  • 128. Asthma through childhood
  • 129. Treatment of chronic asthma
  • 130. The management of acute severe asthma in children
  • 131. Risk-benefit of asthma therapy in children: topical corticosteroids
  • 132. Risk-benefit of asthma therapy: non-steroidal antiinflammatory drugs
  • 133. The natural history of childhood asthma
  • Index